proxyvotesnow.com

Home › Asset managers › Compare 2023-2024 › Charles Schwab vs John Hancock

Charles Schwab vs John Hancock: how alike they voted, 2023-2024

93.8% When both took a single position, they voted the same way on 93.8% of 5,920 items (5,555 the same, 365 different). 446 items where at least one of them split its funds are listed separately below. Both voted on 6,366 items in all.

Charles Schwab 2023-2024 · John Hancock 2023-2024 · Download the item list (CSV)

By who put the item on the ballot. “Same position” = Same / (Same + Differ); split items are not in it. “Fund-level” is a second view over all common items: the chance that a fund of each manager, picked at random, voted the same way, which gives partial credit where a manager split.
Common itemsSame DifferSplit (not in %)Same position Fund-level
All ballot items 6,3665,555365 44693.8%91.0%
Board proposals 5,3634,879281 20394.6%93.2%
E&S shareholder proposals 2216914 13883.1%60.0%
Other items 78260770 10589.7%84.5%

Where they did not vote alike

Everything Voted differently Split votes

All ballot items Board proposals E&S shareholder proposals Other items

446 items. “Voted differently”: each manager’s funds all voted one way, and the two ways differ. “Split”: at least one manager’s funds did not all vote the same way.

CompanyMeetingProposalOn the ballot from Board recommendedCharles SchwabJohn Hancock
KARUNA THERAPEUTICS INC. March 12, 2024 To adjourn the special meeting from time to time, if necessary or appropriate, as determined in good faith by the board of directors of Karuna including for the purpose of soliciting additional votes for the approval of the proposal to adopt the merger agreement if there are insufficient votes at the time of the special meeting to approve the proposal to adopt the merger agreement.
Corporate Governance
Other For FOR
10 funds
Split
4 FOR, 2 AGAINST
KELLANOVA April 26, 2024 Shareowner proposal requesting adoption of a policy requiring the Board Chair to be an independent director, if properly presented at the meeting.
Corporate Governance
Other Against AGAINST
14 funds
Split
5 FOR, 2 AGAINST
LEIDOS HOLDINGS INC. April 26, 2024 Consider stockholder proposal regarding special shareholder meeting improvement, if properly presented.
Corporate Governance
Other Against AGAINST
14 funds
Split
6 FOR, 2 AGAINST
LINCOLN NATIONAL CORP. May 23, 2024 Shareholder proposal to amend our governing documents to provide for an independent chairman of the board.
Corporate Governance
Other Against AGAINST
12 funds
Split
7 FOR, 1 AGAINST
LOCKHEED MARTIN CORP. May 2, 2024 Stockholder Proposal Requesting Reduction in Threshold to Call Special Stockholder Meetings
Corporate Governance
Other Not determined AGAINST
16 funds
Split
8 FOR, 1 AGAINST
LSB INDUSTRIES INC. May 23, 2024 Proposal to approve the Amended and Restated Section 382 Rights Agreement in order to extend the term of the Company's existing rights plan.
Shareholder Rights and Defenses
Other For FOR
7 funds
Split
3 FOR, 1 AGAINST
MARKETAXESS HOLDINGS INC. June 5, 2024 If properly presented, a stockholder proposal to adopt a right to call a special stockholder meeting.
Corporate Governance
Other Against AGAINST
14 funds
Split
4 FOR, 2 AGAINST
MARSH & MCLENNAN COMPANIES INC. May 16, 2024 Stockholder Proposal - Shareholder Right to Act by Written Consent
Corporate Governance
Other Against AGAINST
13 funds
Split
6 FOR, 5 AGAINST
MASTERCARD INC. June 18, 2024 Consideration of a stockholder proposal requesting a director election resignation bylaw
Corporate Governance
Other Against FOR
13 funds
Split
3 FOR, 14 AGAINST
MERCK & CO. INC. May 28, 2024 Shareholder proposal regarding a shareholder right to act by written consent.
Shareholder Rights and Defenses
Other Against AGAINST
15 funds
Split
11 FOR, 8 AGAINST
NETAPP INC. September 13, 2023 To approve a stockholder proposal regarding Special Shareholder Meeting Improvement.
Corporate Governance
Other Against AGAINST
15 funds
Split
7 FOR, 2 AGAINST
NUTANIX INC. December 8, 2023 Approval of the amendment to our Amended and Restated Certificate of Incorporation to permit the exculpation of officers.
Corporate Governance
Other For AGAINST
9 funds
Split
3 FOR, 1 AGAINST
OLIN CORP. April 25, 2024 Shareholder Proposal
Corporate Governance
Other Against FOR
11 funds
Split
4 FOR, 5 AGAINST
PFIZER INC. April 25, 2024 Adopt an Independent Board Chair Policy
Corporate Governance
Other Against AGAINST
15 funds
Split
8 FOR, 6 AGAINST
PFIZER INC. April 25, 2024 Amend Director Resignation Processes
Shareholder Rights and Defenses
Other Against ABSTAIN
15 funds
Split
2 AGAINST, 12 ABSTAIN
PROLOGIS INC. May 9, 2024 Vote on a stockholder proposal titled "Simple Majority Vote."
Corporate Governance
Other Against AGAINST
15 funds
Split
6 FOR, 3 AGAINST
REGENERON PHARMACEUTICALS INC. June 14, 2024 Non-binding shareholder proposal requesting simple majority voting requirements, if properly presented.
Corporate Governance
Other Against FOR
14 funds
Split
6 FOR, 2 AGAINST
SAGE THERAPEUTICS INC. January 31, 2024 To approve a proposal to adjourn the Special Meeting to a later date or dates, if necessary or appropriate, to permit further solicitation and vote of proxies in the event that there are insufficient votes for, or otherwise in connection with, the approval of the Option Exchange Proposal.
Corporate Governance
Other For FOR
5 funds
Split
4 FOR, 2 AGAINST
SALESFORCE INC. June 27, 2024 A stockholder proposal requesting a policy to require the Chair of the Board be an independent member of the Board and not a former CEO of the Company, if properly presented at the meeting.
Corporate Governance
Other Against AGAINST
14 funds
Split
10 FOR, 10 AGAINST
SEADRILL LTD. April 17, 2024 To approve the amended and restated bye-laws as set out in Appendix 2 attached to the Proxy Statement (the A&R Bye-laws) and adopt the A&R Bye-laws to be the bye-laws of the Company in substitution for and to the exclusion of all existing bye-laws of the Company.
Corporate Governance
Other For AGAINST
2 funds
Split
2 FOR, 4 AGAINST
SHOCKWAVE MEDICAL INC. May 29, 2024 To adjourn the Special Meeting of Stockholders to a later date or dates as provided in the Merger Agreement, if necessary or appropriate, including to solicit additional votes if there are insufficient votes to adopt the Merger Agreement at the time of the Special Meeting of Stockholders.
Corporate Governance
Other For FOR
9 funds
Split
9 FOR, 2 AGAINST
SOUTHERN CO. May 22, 2024 Stockholder proposal regarding simple majority vote
Corporate Governance
Other Against AGAINST
12 funds
Split
8 FOR, 2 AGAINST, 1 ABSTAIN
SOUTHWESTERN ENERGY CO. June 18, 2024 Approval of the adjournment of the Southwestern Special Meeting, if necessary or appropriate, to solicit additional votes from shareholders if there are not sufficient votes to adopt the Merger Proposal.
Corporate Governance
Other For FOR
11 funds
Split
6 FOR, 1 AGAINST
SPX TECHNOLOGIES INC. May 14, 2024 Approval of the Amendment to our Certificate of Incorporation to Add a Delaware Forum Selection Provision for Certain Legal Actions.
Shareholder Rights and Defenses
Other For AGAINST
8 funds
Split
5 FOR, 2 AGAINST
SPX TECHNOLOGIES INC. May 14, 2024 Approval of the Amendment to our Certificate of Incorporation to Add a Federal Forum Selection Provision for Claims under the Securities Act of 1933.
Shareholder Rights and Defenses
Other For AGAINST
8 funds
Split
5 FOR, 2 AGAINST
SPX TECHNOLOGIES INC. May 14, 2024 Approval of the Amendment to our Certificate of Incorporation to Provide for Exculpation of Certain Officers as Permitted by Recent Amendments to Delaware Law.
Corporate Governance
Other For FOR
8 funds
Split
5 FOR, 2 AGAINST
STEEL DYNAMICS INC. May 9, 2024 SHAREHOLDER PROPOSAL - ADOPT A SHAREHOLDER RIGHT TO CALL A SPECIAL SHAREHOLDER MEETING
Corporate Governance
Other Not determined AGAINST
14 funds
Split
5 FOR, 2 AGAINST
SUMMIT MATERIALS INC. January 11, 2024 Approve one or more adjournments of the Special Meeting, if necessary or appropriate, to permit solicitation of additional votes if there are insufficient votes to approve the Common Stock Issuance Proposal and/or the Preferred Stock Issuance Proposal.
Corporate Governance
Other For FOR
9 funds
Split
6 FOR, 2 AGAINST
SYNOPSYS INC. April 10, 2024 To vote on a stockholder proposal regarding an independent Board chair requirement, if properly presented at the meeting.
Corporate Governance
Other Against AGAINST
13 funds
Split
4 FOR, 7 AGAINST
TELEFLEX INC. May 3, 2024 Stockholder proposal, if properly presented at the Annual Meeting, to reduce the ownership threshold to call a special stockholder meeting.
Corporate Governance
Other Against AGAINST
14 funds
Split
5 FOR, 10 AGAINST
TESLA INC. June 13, 2024 A stockholder proposal regarding adopting targets and reporting on metrics to assess the feasibility of integrating sustainability metrics into senior executive compensation plans, if properly presented.
Compensation
Other Against AGAINST
14 funds
Split
4 FOR, 5 AGAINST
TESLA INC. June 13, 2024 A stockholder proposal regarding simple majority voting provisions in our governing documents, if properly presented.
Corporate Governance
Other Against FOR
14 funds
Split
7 FOR, 2 AGAINST
TEXAS PACIFIC LAND CORP. November 10, 2023 To consider a non-binding stockholder proposal regarding adopting a policy that requires an independent Chair of the Company's Board of Directors.
Corporate Governance
Other Against AGAINST
12 funds
Split
1 FOR, 2 AGAINST
TPG INC. June 5, 2024 Approve an Amendment to the Company's Certificate of Incorporation Providing for Officer Exculpation under Delaware Law
Corporate Governance
Other For AGAINST
9 funds
Split
2 FOR, 1 AGAINST
UNION PACIFIC CORP. May 9, 2024 Shareholder proposal requesting an amendment to the Safety and Service Quality Committee's charter to review staffing levels and confer on safety issues with stakeholders.
Corporate Governance
Other Not determined AGAINST
13 funds
Split
1 FOR, 10 AGAINST
VERIZON COMMUNICATIONS INC. May 9, 2024 Amend Clawback Policy
Compensation
Other Not determined AGAINST
14 funds
Split
16 FOR, 3 AGAINST
VERIZON COMMUNICATIONS INC. May 9, 2024 Independent Board chair
Corporate Governance
Other Not determined AGAINST
14 funds
Split
16 FOR, 3 AGAINST
VERTEX PHARMACEUTICALS INC. May 15, 2024 Shareholder proposal, if properly presented at the meeting, regarding special shareholder meeting improvement.
Corporate Governance
Other Against AGAINST
15 funds
Split
5 FOR, 5 AGAINST
VISA INC. January 23, 2024 To approve one or more adjournments of the Annual Meeting to a later date or time, if necessary or appropriate, to solicit additional proxies in favor of Proposal 4 if there are insufficient votes at the time of the Annual Meeting to approve such proposal.
Corporate Governance
Other For FOR
15 funds
Split
18 FOR, 4 AGAINST
WESTERN DIGITAL CORP. May 10, 2024 Adjournment of the Special Meeting from time to time to solicit additional proxies in favor of Proposals 1-4 or if otherwise determined by the Chair of the Special Meeting to be necessary or appropriate.
Corporate Governance
Other For AGAINST
14 funds
Split
6 FOR, 4 AGAINST
WISDOMTREE INC. June 12, 2024 To ratify the approval by the Board of Directors of the extension of the Stockholder Rights Agreement, dated March 17, 2023, as amended, by and between the Company and Continental Stock Transfer & Trust Company.
Shareholder Rights and Defenses
Other Contested FOR
5 funds
Split
1 FOR, 3 AGAINST
WORKDAY INC. June 18, 2024 To approve an amendment to our Restated Certificate of Incorporation to reflect Delaware law provisions providing for officer exculpation.
Corporate Governance
Other For AGAINST
10 funds
Split
4 FOR, 9 AGAINST
XEROX HOLDINGS CORP. May 22, 2024 Consider a shareholder proposal requesting a director election resignation bylaw, if properly presented at the meeting.
Corporate Governance
Other Against FOR
8 funds
Split
1 FOR, 3 AGAINST
AARON'S COMPANY INC. May 15, 2024 Approval, on a non-binding, advisory basis, of the Company's named executive officer compensation.
Say-on-Pay
Board For FOR
8 funds
Split
4 FOR, 1 AGAINST
ACCENTURE PLC January 31, 2024 To approve the Amended and Restated Accenture plc 2010 Share Incentive Plan to increase the number of shares available for issuance thereunder.
Compensation
Board For FOR
15 funds
Split
13 FOR, 1 AGAINST
ADOBE INC. April 17, 2024 Approve the 2019 Equity Incentive Plan, as amended, to increase the available share reserve by 5 million shares.
Compensation
Board For FOR
14 funds
Split
12 FOR, 1 AGAINST
ADVANCED MICRO DEVICES INC. May 8, 2024 Approve on a non-binding, advisory basis the compensation of the named executive officers, as disclosed in this proxy statement pursuant to compensation disclosure rules of the U.S. Securities and Exchange Commission.
Say-on-Pay
Board For FOR
16 funds
Split
16 FOR, 3 AGAINST
AGIOS PHARMACEUTICALS INC. June 20, 2024 To elect each of the four Class II director nominees set forth in the Proxy Statement, each to serve for a three-year term expiring at the 2027 annual meeting of stockholders and until his or her respective successor is duly elected and qualified: Kaye Foster
Director Elections
Board For FOR
4 funds
Split
4 FOR, 2 WITHHOLD
AKAMAI TECHNOLOGIES INC. May 10, 2024 To approve an amendment to our Second Amended and Restated 2013 Stock Incentive Plan to increase the number of shares of common stock authorized for issuance thereunder by 5,000,000 shares
Compensation
Board For FOR
13 funds
Split
2 FOR, 5 AGAINST
AMAZON.COM INC. May 22, 2024 ADVISORY VOTE TO APPROVE EXECUTIVE COMPENSATION
Say-on-Pay
Board For FOR
17 funds
Split
11 FOR, 14 AGAINST
AMERANT BANCORP INC. May 8, 2024 To approve, on a non-binding, advisory basis, the compensation of the Company's named executive officers - Say-on-Pay.
Say-on-Pay
Board For FOR
5 funds
Split
5 FOR, 1 AGAINST
AMERICAN TOWER CORP. May 22, 2024 To approve, on an advisory basis, the Company's executive compensation.
Say-on-Pay
Board For FOR
18 funds
Split
17 FOR, 1 AGAINST
AMTECH SYSTEMS INC. March 6, 2024 To approve the advisory (non-binding) resolution relating to the named executive officer compensation as disclosed in the accompanying proxy statement and
Say-on-Pay
Board For AGAINST
2 funds
Split
1 FOR, 1 AGAINST
APTIV PLC April 24, 2024 Proposal to re-appoint auditors, ratify independent public accounting firm and authorize the directors to determine the fees paid to the auditors.
Audit-related
Board For FOR
13 funds
Split
5 FOR, 1 AGAINST
ARCTURUS THERAPEUTICS HOLDINGS INC. June 14, 2024 To approve an amendment to the Amended and Restated 2019 Omnibus Equity Incentive Plan (as amended, the "Plan") to, among other things, increase the maximum number of shares of common stock available to Plan participants thereunder by 2,000,000 shares to an aggregate of 10,750,000 shares, as provided in Proposal Number 2 of the Proxy Statement.
Compensation
Board For FOR
4 funds
Split
1 FOR, 4 AGAINST
ARIS WATER SOLUTIONS INC. May 9, 2024 Amend the Aris Water Solutions, Inc. 2021 Equity Incentive Plan to increase the number of shares of common stock that may be issued under the plan.
Compensation
Board For FOR
2 funds
Split
1 FOR, 3 AGAINST
ASGN INC. June 13, 2024 Election of the following Class II Directors for the three-year period expiring at our 2027 Annual Meeting of Stockholders: Joseph W. Dyer
Director Elections
Board For FOR
8 funds
Split
6 FOR, 1 AGAINST
ATARA BIOTHERAPEUTICS INC. June 10, 2024 To approve the Company's 2024 Equity Incentive Plan
Compensation
Board For FOR
3 funds
Split
2 FOR, 1 AGAINST
ATLASSIAN CORP. December 6, 2023 An advisory vote to approve the fiscal year 2023 compensation of our named executive officers.
Say-on-Pay
Board For AGAINST
10 funds
Split
4 FOR, 2 AGAINST
ATRICURE INC. May 13, 2024 Advisory vote on the compensation of our named executive officers as disclosed in the proxy statement for the 2024 Annual Meeting.
Say-on-Pay
Board For AGAINST
6 funds
Split
5 FOR, 2 AGAINST
AVANTAX INC November 21, 2023 Proposal to approve, by a non-binding advisory vote, the compensation that may be paid or become payable to Avantax, Inc.'s named executive officers that is based on, or otherwise relates to, the merger of C2023 Sub Corp. with and into Avantax, Inc., as contemplated by the merger agreement.
Say-on-Pay
Board For AGAINST
5 funds
Split
4 FOR, 1 AGAINST
AXON ENTERPRISE INC. May 10, 2024 Proposal No. 2 requests that shareholders vote to approve the Axon Enterprise, Inc. Amended and Restated 2022 Stock Incentive Plan.
Compensation
Board For FOR
11 funds
Split
2 FOR, 8 AGAINST
BANK OF AMERICA CORP. April 24, 2024 Amending and restating the Bank of America Corporation Equity Plan
Compensation
Board For FOR
13 funds
Split
4 FOR, 16 AGAINST
BARNES GROUP INC. May 3, 2024 Vote on a non-binding resolution to approve the Company's executive compensation.
Say-on-Pay
Board For FOR
9 funds
Split
5 FOR, 1 AGAINST
BEAM THERAPEUTICS INC. June 5, 2024 Election of the following nominee as a Class I Director for a three-year term ending at our Annual Meeting of Stockholders to be held in 2027: Graham Cooper
Director Elections
Board For FOR
5 funds
Split
2 FOR, 3 AGAINST
BIG LOTS INC. May 29, 2024 APPROVAL, ON AN ADVISORY BASIS, OF THE COMPENSATION OF OUR NAMED EXECUTIVE OFFICERS. The Board of Directors recommends a vote FOR the approval of the compensation of Big Lots' named executive officers, as disclosed in the Proxy Statement pursuant to Item 402 of Regulation S-K, including the Compensation Discussion and Analysis, compensation tables and narrative discussion accompanying the tables.
Say-on-Pay
Board For FOR
8 funds
Split
4 FOR, 1 AGAINST
BRIGHTVIEW HOLDINGS INC. March 5, 2024 To approve the amendment to the BrightView Holdings, Inc. Amended and Restated 2018 Omnibus Incentive Plan.
Compensation
Board For FOR
7 funds
Split
2 FOR, 4 AGAINST
BURLINGTON STORES INC. May 22, 2024 Approval, on a non-binding advisory basis, of the compensation of Burlington Stores, Inc.'s named executive officers
Say-on-Pay
Board For AGAINST
13 funds
Split
9 FOR, 2 AGAINST
CAPRI HOLDINGS LTD. October 25, 2023 To approve, on an advisory (nonbinding) basis, the compensation that may be paid or become payable to Capri Holdings Limited's named executive officers that is based on or otherwise relates to the Merger Agreement and the transactions contemplated by the Merger Agreement.
Say-on-Pay
Board For AGAINST
12 funds
Split
3 FOR, 4 AGAINST
CAPSTAR FINANCIAL HOLDINGS INC. February 29, 2024 To approve, on a non-binding, advisory basis, the merger-related named executive officer compensation that will or may be paid to CapStar Financial Holdings, Inc.'s named executive officers in connection with the transactions contemplated by the Merger Agreement.
Say-on-Pay
Board For AGAINST
3 funds
Split
4 FOR, 1 AGAINST
CARGURUS INC. June 5, 2024 To approve, on a non-binding advisory basis, the compensation of the Company's named executive officers for 2023.
Say-on-Pay
Board For FOR
8 funds
Split
8 FOR, 1 AGAINST
CARRIER GLOBAL CORP. April 18, 2024 Advisory Vote to Approve Named Executive Officer Compensation
Say-on-Pay
Board For FOR
16 funds
Split
8 FOR, 1 AGAINST
CARROLS RESTAURANT GROUP INC. May 14, 2024 To approve, on an advisory (non-binding) basis, the compensation that will or may become payable by Carrols to its named executive officers in connection with the merger of BK Cheshire Corp. with and into Carrols Restaurant Group, Inc.
Say-on-Pay
Board For AGAINST
3 funds
Split
4 FOR, 1 AGAINST
CBOE GLOBAL MARKETS INC. May 16, 2024 Approve, in a non-binding resolution, the compensation paid to our executive officers.
Say-on-Pay
Board For FOR
16 funds
Split
7 FOR, 2 AGAINST
CERENCE INC. February 15, 2024 Approval, on a non-binding, advisory basis, of the compensation of our named executive officers, as disclosed in this proxy statement; and
Say-on-Pay
Board For FOR
9 funds
Split
5 FOR, 1 AGAINST
CHECK POINT SOFTWARE TECHNOLOGIES LTD. August 3, 2023 Election of Director: Jill D. Smith
Director Elections
Board For FOR
4 funds
Split
5 FOR, 1 AGAINST
CHESAPEAKE ENERGY CORP. June 18, 2024 Approval of, by non-binding, advisory vote, certain compensation arrangements for Chesapeake's named executive officers in connection with the merger contemplated by the Merger Agreement.
Say-on-Pay
Board For FOR
13 funds
Split
1 FOR, 10 AGAINST
CHIPOTLE MEXICAN GRILL June 6, 2024 An advisory vote to approve the compensation of our executive officers as disclosed in the proxy statement ("say-on-pay").
Say-on-Pay
Board For FOR
15 funds
Split
11 FOR, 1 AGAINST
CHUBB LIMITED May 16, 2024 Election of Evan G. Greenberg as Chairman of the Board of Directors
Corporate Governance
Board For FOR
12 funds
Split
5 FOR, 9 AGAINST
CITIGROUP INC. April 30, 2024 Approval of additional shares for, and a term extension and restatement of, the Citigroup 2019 Stock Incentive Plan.
Compensation
Board For FOR
12 funds
Split
5 FOR, 9 AGAINST
CLEARWATER ANALYTICS HOLDINGS INC. June 11, 2024 Elect the three persons named in the proxy statement as Class III directors for terms of three years: Eric Lee
Director Elections
Board For FOR
3 funds
Split
1 FOR, 2 WITHHOLD
CONAGRA BRANDS INC. September 14, 2023 Advisory vote to approve named executive officer compensation
Say-on-Pay
Board For FOR
14 funds
Split
8 FOR, 2 AGAINST
CONFLUENT INC. June 12, 2024 Approval, on a non-binding advisory basis, of the compensation of our named executive officers, as disclosed in the Proxy Statement.
Say-on-Pay
Board For FOR
9 funds
Split
6 FOR, 2 AGAINST
CONSTELLATION BRANDS INC. July 18, 2023 To approve, by an advisory vote, the compensation of the Company's named executive officers as disclosed in the Proxy Statement.
Say-on-Pay
Board For FOR
17 funds
Split
10 FOR, 1 AGAINST
CONSTELLIUM SE May 2, 2024 Authorization to be given to the Board to freely allocate shares, to be issued or existing, under the Constellium SE 2013 Equity Incentive Plan, for a 38-month-period, up to 6,000,000 ordinary shares of the Company.
Capital Structure
Board For FOR
5 funds
Split
1 FOR, 3 AGAINST
CONSTELLIUM SE May 2, 2024 Delegation of competence to the Board to increase the number of shares issued in case of a capital increase, without preferential subscription rights, by way of a public offering other than within the meaning of article L411-2 1 of the French Monetary and Financial Code, in accordance with article L225-135-1 of the French Commercial Code, by up to 15%, for a 15 month-period.
Capital Structure
Board For AGAINST
5 funds
Split
1 FOR, 3 AGAINST
CONSTELLIUM SE May 2, 2024 Re-appointment of Mr. Jean-Christophe Deslarzes as a director for a term of three years.
Director Elections
Board For FOR
5 funds
Split
1 FOR, 3 AGAINST
CONSTELLIUM SE May 2, 2024 Re-appointment of Ms. Isabelle Boccon-Gibod as a director for a term of three years.
Director Elections
Board For FOR
5 funds
Split
1 FOR, 3 AGAINST
COPART INC. December 8, 2023 To approve, on an advisory (non-binding) basis, the compensation of our named executive officers for the fiscal year ended July 31, 2023
Say-on-Pay
Board For FOR
16 funds
Split
2 FOR, 6 AGAINST
CORPAY INC. June 6, 2024 Advisory vote to approve named executive officer compensation.
Say-on-Pay
Board For FOR
17 funds
Split
11 FOR, 2 AGAINST
CRINETICS PHARMACEUTICALS INC. June 7, 2024 To elect two directors to serve as Class III directors for a three-year term to expire at the 2027 annual meeting of stockholders: Camille Bedrosian, M.D.
Director Elections
Board For FOR
4 funds
Split
7 FOR, 3 WITHHOLD
CRISPR THERAPEUTICS AG May 30, 2024 Approval of amendments to the Articles of Association to facilitate the use of equity compensation and pension benefits programs consistent with current market practices.
Compensation
Board For FOR
4 funds
Split
1 FOR, 2 AGAINST
CRISPR THERAPEUTICS AG May 30, 2024 Approval of an amendment to the CRISPR Therapeutics AG 2018 Stock Option and Incentive Plan.
Compensation
Board For FOR
4 funds
Split
1 FOR, 2 AGAINST
CRISPR THERAPEUTICS AG May 30, 2024 Approval of an increase of the conditional share capital for employee equity plans.
Compensation
Board For AGAINST
4 funds
Split
1 FOR, 2 AGAINST
CRYOPORT INC. May 17, 2024 To approve an amendment to the Cryoport, Inc. 2018 Omnibus Equity Incentive Plan to increase the number of authorized shares for issuance thereunder from 7,850,000 to a total of 10,350,000; and
Compensation
Board For FOR
4 funds
Split
3 FOR, 2 AGAINST
CSX CORP. May 8, 2024 Advisory (non-binding) resolution to approve compensation for the Company's named executive officers.
Say-on-Pay
Board For FOR
15 funds
Split
7 FOR, 1 AGAINST
DELL TECHNOLOGIES INC. June 27, 2024 Approval, on an advisory basis, of the compensation of Dell Technologies Inc.'s named executive officers as disclosed in the proxy statement
Say-on-Pay
Board For FOR
8 funds
Split
9 FOR, 1 AGAINST
DIAMONDBACK ENERGY INC. April 26, 2024 Charter Amendment Proposal: To adopt an amendment to the Second Amended and Restated Certificate of Incorporation of Diamondback (the "Charter") to increase the total number of authorized shares of common stock under the terms of the Charter from 400 million shares to 800 million shares of common stock.
Capital Structure
Board For FOR
13 funds
Split
11 FOR, 2 AGAINST
DUPONT DE NEMOURS INC. June 5, 2024 Advisory Resolution to Approve Executive Compensation
Say-on-Pay
Board For FOR
15 funds
Split
8 FOR, 2 AGAINST
EASTMAN CHEMICAL CO. May 2, 2024 Advisory Approval of Executive Compensation as Disclosed in Proxy Statement
Say-on-Pay
Board Not determined FOR
15 funds
Split
5 FOR, 2 AGAINST

← Previous Page 3 of 5 Next →

← All 20 managers, 2023-2024

How items are matched and positions counted: see the comparison table and the methodology. Built October 25, 2026 from SEC Form N-PX filings.